Home › Trial NCT02753881
Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
- Trial IDNCT02753881
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorYale University
- Enrollment30
- Start date2015-11
- ConditionsLiver Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.